Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

March 4, 2016March 4, 2016

Musculoskeletal Diseases Like Rheumatoid Arthritis Cost $213 Billion a Year in Treatment, Lost Wages

News

Musculoskeletal diseases, including rheumatoid arthritis, affect more than one out of every two people in the U.S. age 18 and over, and nearly three out of four age 65 and over ... Read more

March 2, 2016March 2, 2016

FDA Approves Once-Daily Rheumatoid Arthritis Oral Drug, Xeljanz XR, by Pfizer

News

Pfizer, Inc., recently announced that the U.S. Food and Drug Administration (FDA) has approved Xeljanz XR (tofacitinib citrate) extended-release 11 mg tablets as a once-daily treatment of patients with moderate to severe ... Read more

February 29, 2016February 29, 2016

Rheumatoid Arthritis Not Seen to Raise Person’s Risk of Cardiovascular Complications Due to Surgery

News

Patients with rheumatoid arthritis (RA) have a high overall incidence of mortality, primarily due to cardiovascular complications. But RA patients are not at increased risk for post-surgery cardiovascular complications or death compared ... Read more

February 17, 2016February 17, 2016

Serious RA Infections May Be Linked to Opioid Use, Study Reports

News

Researchers at Vanderbilt University Medical Center report that the use of opioid analgesics by patients with rheumatoid arthritis may increase their likelihood of serious infection and subsequent hospitalization. Their study, “Opioid Analgesics and ... Read more

February 10, 2016February 10, 2016

African-Americans with Rheumatoid Arthritis and Like Diseases at Cardiovascular Risk

News

Research conducted into the medical records of over a quarter million adults found that African-Americans with connective tissue diseases such as rheumatoid arthritis are twice as likely as whites with these diseases to suffer complications that increase ... Read more

February 8, 2016February 8, 2016

Potential Rheumatoid Arthritis Therapy Seen in a Naturally Produced Protein Called TTP

News

Increasing the levels of tristetraprolin (TTP), a protein naturally produced in the body, helped to reduce or protect mice against inflammation, a study found, suggesting that pharmaceutical compounds capable of ... Read more

January 27, 2016January 27, 2016

Rheumatoid Arthritis Risk Increases Greatly With Exposure to Occupational Textile Dust

News

Occupational exposure to textile dust more than doubles the risk of developing rheumatoid arthritis, according to a study published in the Annals of the Rheumatic Diseases titled “Occupational exposure to textile dust increases ... Read more

December 21, 2015December 21, 2015

Potential Rheumatoid Arthritis Drug Finishing Key Round of Phase 3 Testing

News

GlaxoSmithKline announced positive topline data from the Phase 3 program studying sirukumab, an investigational human anti-IL-6 monoclonal antibody, for the treatment of patients with a diagnosis of moderately to severely active rheumatoid ... Read more

December 16, 2015December 16, 2015

Rheumatoid Arthritis Pain, Activity Cut with Potassium Supplements

News

Treating rheumatoid arthritis (RA) patients with oral potassium supplements can be an effective and “gentle” way to reduce pain and disease activity, according to the results of a study, “Oral Potassium ... Read more

December 11, 2015December 11, 2015

Older Rheumatoid Arthritis Patients May Underestimate Disease Activity

News

Decreased levels of perceived pain may cause older patients with rheumatoid arthritis to underestimate disease activity compared to younger patients. These findings, which have clinical implications for current measurements of ... Read more